CONFERENCE SCHEDULE
WEDNESDAY, SEPTEMBER 8, 2021 - GENERAL LIFE SCIENCE DAY
All times are in Eastern Time Zone - USA
9:00am // OPENING REMARKS
9:10am // KEYNOTE SPEAKER - Dennis Purcell, Founder Aisling Capital, Life Sciences. Topic: Where do we go from here?
9:40am // Corporate Presentation - Pixel Technology
10:00 am // Corporate Presentation - Patia
10:20 am // Corporate Presentation - Cipher Surgical
10:40 am // Corporate Presentation - VitalTech
11:00 am // Corporate Presentation - Tactical Therapeutics
11:20 am // Corporate Presentation - Imaginostics
11:40 am // Corporate Presentation - Feldan Therapeutics
12:00 pm // Corporate Presentation - Intrommune Therapeutics
12:20 pm // Corporate Presentation - Entac Medical
12:40 pm // Corporate Presentation - LifeOmic
1:00 pm // SPEAKER - Chris Apfel, Chair, Keiretsu Forum Life Sciences | CEO, SageMedic. Topic: Sage Advice for Investors: How to Pick Winners in Life Sciences
1:30 pm // Corporate Presentation - Travel Telemed
1:50 pm // Corporate Presentation - True Digital Surgery
2:10 pm // Corporate Presentation - Spine Thera
2:30 pm // Corporate Presentation - Taiga Biotechnologies
2:50 pm // Corporate Presentation - Tetra Biopharma
3:10 pm // Corporate Presentation - NanoView Biosciences
3:30 pm // Corporate Presentation - Thrive Bioscience
3:50 pm // Corporate Presentation - AseptiScope
4:10 pm // Corporate Presentation - Biovista
4:30 pm // Corporate Presentation - SageMedic
4:50 pm // SPEAKER - Alfred Slanetz, CEO, Geneius |Former CEO, Bluebird Bio | Former Director Product Development, Genetech. Topic: T-cell Therapies for Cancer
5:30 pm // CLOSING REMARKS
THURSDAY, SEPTEMBER 9, 2021 - NEUROLOGY DAY
All times are in Eastern Time Zone - USA
9:00am // OPENING REMARKS
9:10am // KEYNOTE SPEAKER - Rakesh Jain, Andrew Werk Cook Professor of Tumor Biology, Massachusetts General Hospital in the Harvard Medical School | Director of the E.L. Steele Laboratories for Tumor Biology at the Massachusetts General Hospital. Topic: Improving Treatment of Primary and Metastatic Brain Tumors
9:50am // SPEAKERS - Susan Ano, Tech Transfer Director, National Institute of Neurological Disorders and Stroke/NHI. Jenny Wong, Tech Transfer Director, National Institute of Mental Health/NHI. Topic: Tech Transfers within the National Institute of Health
10:20 am // Corporate Presentation - Biorchestra
10:40 am // Corporate Presentation - Herantis Pharma
11:00 am // Corporate Presentation - MitoImmune Therapeutics
11:20 am // Corporate Presentation - STALICLA
11:40 am // Corporate Presentation - Sinntaxis
12:00 pm // Corporate Presentation - NeuroGeneces
12:20 pm // Corporate Presentation - Neurovine
12:40 pm // Corporate Presentation - Epivario
1:00 pm // SPEAKER - Fred Nazem, Former CEO/Chair, Oxford Health | CEO, Rejuvenan. Topic: The Silent and Growing Pandemic of Parkinson’s and Neurodegenerative Diseases
1:30 pm // Corporate Presentation - TTM Therapeutics
1:50 pm // Corporate Presentation - Healium
2:10 pm // Corporate Presentation - Lief Therapeutics
2:30 pm // Corporate Presentation - StimScience
2:50 pm // Corporate Presentation - SCYiBL
3:10 pm // Corporate Presentation - Cerevance
3:30 pm // Corporate Presentation - Cognoptix
3:50 pm // Corporate Presentation - Emtensor
4:10 pm // Corporate Presentation - NeuroDex
4:30 pm // Corporate Presentation - Celero Systems
4:50 pm // Corporate Presentation - De Oro Devices
5:10 pm // Corporate Presentation - Kinoxis Therapeutics
5:30 pm // SPEAKER - Francesca Bosetti, Stroke Program Director, National Institute of Neurological Disorders and Stroke/NHI. Topic: Neuroprotection in ischemic stroke: the past, the present and the future
5:50 pm // PANEL DISCUSSION - Moderator: Varun Renjen, Associate Principal, Blue Matter Consulting. Henri Sant Cassia, Co-founder and Managing Partner, The Conscious Fund, Doug Drysdale, CEO, Cybin Pharmaceuticals. Jim Kuo, CEO, Return Health. Olivia Mannix, Founder, Chief Strategy Officer, Aphrodite Health. Suran Goonatilake, Co-Founder April 19 Discovery Inc. Topic: Renaissance of Psychedelics in CNS medicine
6:30 pm // CLOSING REMARKS